Antara Capital LP
- SEC CIK
- 0001750183
- Latest filing
- Feb 17, 2026
The latest 13F from Antara Capital LP covers Q4 2025 (filed Feb 17, 2026): 2 long positions worth $30.2K. The top 10 holdings make up 100.0% of the portfolio, and the largest is Aspire Biopharma Holdings, Inc. (ASBP) at 88.6%. Livermore has 21 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q4 2025
Share counts compared with Q3 2025: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 0
- Added
- 0
- Reduced
- 0
- Sold out
- 1
- Est. −$442.2K
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
None this quarter.
Largest weight increases
New and added positions, by percentage points of the portfolio gained
None this quarter.
Metrics
13F metrics for Q4 2025, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $30.2K
- −$460.0K (−93.8%) vs. prior quarter
- Positions
- 2
- −1 vs. prior quarter
- Top 10 concentration
- 100.0%
- Top 10 as share of value
- Turnover
- 0.0%
- Q4 2025, one quarter
- Average holding period
- 2.0 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
20 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $1.28B (Q1 2022)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q4 2025 | Feb 17, 2026 | 2 | $30.2K | ASBPASBPW | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 14, 2025 | 3 | $490.2K | CURRASBPASBPW | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 2 | $1.12M | CURRRZLV | vs. Q1 2025 | SEC |
| Q1 2025 | May 15, 2025 | 12 | $88.8K | THCHXAGEHeramba Elec PLC | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 14, 2025 | 20 | $48.9M | Western Digital CorpVentas Rlty Ltd PartnershipBRSL | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 14, 2024 | 24 | $19.2M | EDRINVZCZR | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 14, 2024 | 24 | $61.0M | CHPTACIBRSL | vs. Q1 2024 | SEC |
| Q1 2024 | May 14, 2024 | 25 | $43.0M | iShares TrCHPTUHG | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024 | 25 | $26.1M | FLYYUHGInnoviz Technologies Ltd. | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 14, 2023 | 38 | $59.0M | HCVIClean Earth Acquisitions CorPEGR | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 14, 2023 | 45 | $81.0M | INVZUHGClean Earth Acquisitions Cor | vs. Q1 2023 | SEC |
| Q1 2023 | May 12, 2023 | 54 | $370.6M | FLYYNKLAACI | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 13, 2023 | 95 | $825.6M | FLYYVMWBKI | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 144 | $903.9M | ATVICLRINVZ | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 15, 2022 | 222 | $967.2M | Clovis Oncology, Inc.DraftKings Inc.Uber Technologies, Inc | vs. Q1 2022 | SEC |
| Q1 2022 | May 16, 2022 | 225 | $1.28B | DraftKings Inc.Sea LtdClovis Oncology, Inc. | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 14, 2022 | 190 | $1.03B | HTZClovis Oncology, Inc.INVZ | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 15, 2021 | 137 | $508.3M | Clovis Oncology, Inc.INVZSea Ltd | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 16, 2021 | 154 | $553.2M | INVZClovis Oncology, Inc.DELL | vs. Q1 2021 | SEC |
| Q1 2021 | Sep 23, 2021Amended | 86 | $384.1M | Clovis Oncology, Inc.Paramount GlobalSoaring Eagle Acquisition Co | – | SEC |
13D and 13G filings
Companies where Antara Capital LP reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
Antara Capital LP does not currently report owning 5% or more of any company.
Latest filings
67 filings on file made by Antara Capital LP or listing it as a reporting person; the latest 20 are shown.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| INVZInnoviz Technologies Ltd. | May 15, 20255:46 PM ET | 13G/A | 2.05%4.06M shares | −2.98 ppfrom 5.03%Below 5% | Mar 31, 2025 | SEC |
| NKLANikola Corp | May 15, 20254:17 PM ET | 13G/A | 2.68%3.17M shares | −6.15 ppfrom 8.83%Below 5% | Mar 31, 2025 | SEC |
| INVZInnoviz Technologies Ltd. | Feb 14, 20259:56 AM ET | 13G/A | 5.03%8.48M shares | – | Dec 31, 2024 | SEC |
| NKLANikola Corp | Feb 14, 20259:54 AM ET | 13G | 8.83%10.1M shares | New | Dec 31, 2024 | SEC |
| KRNLKernel Group Holdings, Inc. | Nov 14, 2024 | 13G/AOld format | – | – | – | SEC |
| UHGUnited Homes Group, Inc. | Nov 14, 2024 | 13G/AOld format | – | – | – | SEC |
| INVZInnoviz Technologies Ltd. | Nov 14, 2024 | 13G/AOld format | – | – | – | SEC |
| CTLPCantaloupe, Inc. | Nov 14, 2024 | 13G/AOld format | – | – | – | SEC |
| ATEKAthena Technology Acquisition Corp. II | Nov 14, 2024 | 13G/AOld format | – | – | – | SEC |
| Direct Selling Acquisition Corp. | May 13, 2024 | 13G/AOld format | – | – | – | SEC |
| Arrival | Feb 14, 2024 | 13G/AOld format | – | – | – | SEC |
| INVZInnoviz Technologies Ltd. | Feb 14, 2024 | 13G/AOld format | – | – | – | SEC |
| GANGAN Ltd | Feb 14, 2024 | 13G/AOld format | – | – | – | SEC |
| SCPLSciPlay Corp | Feb 14, 2024 | 13G/AOld format | – | – | – | SEC |
| RVNCRevance Therapeutics, Inc. | Feb 14, 2024 | 13G/AOld format | – | – | – | SEC |
| UHGUnited Homes Group, Inc. | Feb 14, 2024 | 13GOld format | – | New | – | SEC |
| KRNLKernel Group Holdings, Inc. | Feb 14, 2024 | 13GOld format | – | New | – | SEC |
| ANNAAleAnna, Inc. | Feb 14, 2024 | 13G/AOld format | – | – | – | SEC |
| VRMVroom, Inc. | Feb 14, 2024 | 13G/AOld format | – | – | – | SEC |
| XAGELongevity Health Holdings, Inc. | Feb 14, 2024 | 13G/AOld format | – | – | – | SEC |